Our Platform
Sponsors/CROs
Ophthalmology Sites that Start Fast and Enroll Reliably
Sponsors and CROs come to Macro for delivery they can plan around: feasibility responses in 5 business days and studies up and running about 6 weeks after site qualification. One contract and one point of contact cover the whole network.
Our Network
The Macro Site Network includes Macro-managed sites, where Macro operates every research function from feasibility through close-out, and Macro-supported sites, established research practices that contract through Macro for site identification, budgets, and agreements. Either way, sponsors work with one point of contact and one contracting process across the network.
One contract. One budget. One point of contact.
Across every site in the network, sponsors and CROs sign one contract, negotiate one budget, and work with one point of contact. No chasing individual sites, no reconciling separate agreements.
Delivery you can plan around
5 days
5 business days to a feasibility response.
6 weeks
About 6 weeks from site qualification to study start.
A strong investigator bench
Studies across the network are run by 30+ investigators across the network, an experienced ophthalmology research bench.
Ophthalmology, end to end
Macro delivers consistent, high-performing site operations across the full spectrum of ophthalmology, from anterior segment through retina. Our investigators have extensive experience across the full spectrum of the eye: retina, glaucoma, cornea, dry eye, and thyroid eye disease, including complex biologics, devices, and interventional protocols.
Ophthalmology research is its own discipline
Ophthalmology research is its own discipline
Protocol-defined ETDRS acuity is read by certified examiners, and OCT, FAF, and angiography are acquired on-site and graded masked by independent reading centers.
Treatment is often a procedure
Many protocols call for sterile intravitreal injections given by certified injectors, not a prescription and a blood draw.
Visits are procedure-dense
Dilation, certified acuity, IOP, several imaging modalities, injection, and safety checks add up to two or three hours a month, often in an elderly population.
Every indication has its own instrument set and endpoint logic
Built once, re-used across every trial
- Standardized ophthalmology SOPs and source templates shared across the network.
- A coordinator pool fluent in imaging acquisition, masking, and injection-visit logistics.
- Sites and technicians certified once, so studies two and three activate faster than study one.
- Standing reading-center relationships.
- Indication-level feasibility intelligence on which practices can truly deliver.
A generalist SMO rebuilds this capability for every eye study. Macro builds it once and re-uses it across the full spectrum of the eye.
Clinical Trial Execution: Important, Complex Problem
For clinical trials that do complete, there is a high degree of post-market failures due to relevance and applicability in real-world settings.
%
Today 50% of new treatments fail due to non drug efficacy-related reasons.
%
86% of clinical trial sites do not meet enrollment goals.
For CROs
When you place many sites at once, you need answers you can trust and a single point of accountability. Macro gives you both.
- Feasibility responses in 5 business days.
- Accurate patient counts, not inflated promises.
- One contact who speaks for many sites, so you are not managing dozens of relationships.
Let’s talk about making Macro a preferred site network for your next ophthalmology program.
Macro is the commercial single point of contact at every network site: feasibility routing, contracting, and budgets. At Macro-supported sites, operational delivery is led by the site’s own experienced research team, and Macro only presents sites it has vetted.
Request a capability review
Tell us about your program and we’ll show you what the network can deliver.